Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Operating Leases (2019 - 2021)

Phio Pharmaceuticals' Operating Leases history spans 3 years, with the latest figure at $314000.0 for Q3 2021.

  • For Q3 2021, Operating Leases fell 3.38% year-over-year to $314000.0; the TTM value through Sep 2021 reached $314000.0, down 3.38%, while the annual FY2020 figure was $295000.0, 43.05% down from the prior year.
  • Operating Leases reached $314000.0 in Q3 2021 per PHIO's latest filing, up from $234000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $518000.0 in Q4 2019 to a low of $234000.0 in Q2 2021.
  • Average Operating Leases over 3 years is $391909.1, with a median of $438000.0 recorded in 2019.
  • Peak YoY movement for Operating Leases: changed 0.0% in 2020, then plummeted 49.68% in 2021.
  • A 3-year view of Operating Leases shows it stood at $518000.0 in 2019, then crashed by 43.05% to $295000.0 in 2020, then rose by 6.44% to $314000.0 in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Operating Leases are $314000.0 (Q3 2021), $234000.0 (Q2 2021), and $265000.0 (Q1 2021).